BRIEF-EMA Says Increased Manufacturing Capacity For COVID-19 Vaccine Janssen

BRIEF-EMA Says Increased Manufacturing Capacity For COVID-19 Vaccine Janssen

European Medicines Agency:

* EMA: INCREASED MANUFACTURING CAPACITY FOR COVID-19 VACCINE JANSSEN: 02/07/2021

* EMA SAYS PLANT, WHICH IS LOCATED IN LEIDEN, NETHERLANDS, PRODUCES ALL ACTIVE SUBSTANCE FOR MANUFACTURE OF EU SUPPLY OF COVID-19 VACCINE JANSSEN

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.